Referred to the House Committee on Financial Services.
This joint resolution disapproves and nullifies the Bureau of Consumer Financial Protection rule titled "Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V)" (90 Fed. Reg. 3276, Jan 14, 2025).
Privacy vs deregulation: left stresses medical privacy; right stresses regulatory restraint.
Relative to its intended legislative type, this bill is a narrowly focused disapproval resolution that clearly identifies the specific rule to be nullified and states the legal result, but it omits fiscal discussion, handling of transitional or retroactive effects, and any follow-up oversight or implementation detail.
This joint resolution disapproves and nullifies the Bureau of Consumer Financial Protection rule titled "Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V)" (90 Fed.
Reg. 3276, Jan 14, 2025).
If enacted, the resolution would render that CFPB rule "no force or effect."
Narrow administrative repeal with low fiscal impact but partisan regulatory implications; outcome hinges on Senate dynamics and executive position.
Relative to its intended legislative type, this bill is a narrowly focused disapproval resolution that clearly identifies the specific rule to be nullified and states the legal result, but it omits fiscal discussion, handling of transitional or retroactive effects, and any follow-up oversight or implementation detail.
Privacy vs deregulation: left stresses medical privacy; right stresses regulatory restraint.
These are examples from the analysis, not a ranked list of the most-affected groups.
Privacy vs deregulation: left stresses medical privacy; right stresses regulatory restraint.
Likely opposed.
They would view the CFPB rule's prohibition on creditors and consumer reporting agencies using medical information as a consumer privacy protection.
Nullifying that rule raises concerns about medical privacy, discrimination, and weaker consumer safeguards.
Mixed/leaning cautious.
They would weigh consumer privacy protections against regulatory costs and possible impacts on credit markets.
They would likely seek more evidence on harms and benefits before committing to full support or opposition.
Likely supportive.
They would frame the resolution as checking CFPB overreach and removing a rule that restricts creditors and reporting agencies.
Emphasis on reducing regulation, preserving market flexibility, and limiting administrative power.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow administrative repeal with low fiscal impact but partisan regulatory implications; outcome hinges on Senate dynamics and executive position.
The bill has not accumulated any surfaced votes yet.
Privacy vs deregulation: left stresses medical privacy; right stresses regulatory restraint.
Narrow administrative repeal with low fiscal impact but partisan regulatory implications; outcome hinges on Senate dynamics and executive p…
Relative to its intended legislative type, this bill is a narrowly focused disapproval resolution that clearly identifies the specific rule to be nullified and states the legal result, but it omits fiscal discussion, ha…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.